CRA’s Life Sciences Practice helps pharmaceutical, biotechnology, medical devices and digital health companies achieve optimum performance across key aspects of their business including commercial strategy, pricing and access, innovation, organisation structure, policy analysis, medical affairs, stakeholder management, and reputation, all for the long-term benefit of patients, clinicians, employees, and shareholders. We work with life sciences businesses directly as well as with their legal counsel, industry associations, government organisations, and advocacy groups.
The CRA Life Sciences team operates from offices across the United States, UK and Europe, providing insights on global issues and local market challenges across all geographies.